Global Scar Treatment market is estimated to be valued at US$ 12,020.5 million in 2023 and is expected to exhibit a CAGR of 4.5% during the forecast period (2023-2030).
Scars form as part of the healing process after a cut or injury to the skin. The skin repairs itself by forming new tissue to contract wounds and fill gaps caused by injury. Scar tissue is primarily composed of a protein called collagen. Dark-skinned people (especially African, Asian, or Hispanic people), and people with red hair are more likely to develop keloid scars, which grow beyond the damaged area. Depending on the size, type, and location of the scar, it can be unsightly and difficult to move. Not all scars require treatment and many fade over time. Treatment can help if scars are bothersome or causing pain.
Analysts’ Views on Global Scar Treatment Market:
Rising demand for scar treatment options to treat burn injuries is expected to drive the market growth over the forecast period. For instance, in February 2020, according to a report published by the National Centre for Biotechnology Information (NCBI), stated that according to The American Burn Association (ABA) National Burn Repository, 41% of the injuries in the U.S. are burn injuries.
Figure 1. Global Scar Treatment Market Share (%), by Product Type, 2023
Global Scar Treatment Market- Driver
Increasing incidence of surgeries
The global scar treatment is used in treatment of scars caused due to surgeries. Thus, increasing rate of surgical operations is expected to drive the market growth over the forecast period. For instance, in March 2022, according to a report published by John Wiley & Sons, Inc., a research and education company, it was reported that in a survey conducted on people living in Brazil, China, France, Russia and the U.S., 35% of women and 28% of men indicated that scarring was caused due to general or orthopedic surgery.
Increasing incidence of burn injuries
Scar treatment is used for the treatment of scars caused due to burn injuries, and thus, the increasing incidence of burn injuries is expected to drive the market growth over the forecast period. For instance, in December 2022, according to an article published in Springer Nature, which is a scientific journal, it was reported that the 67% of the scars were caused due to burn injuries in the U.S.
Figure 2. Global Scar Treatment Market Share (%), by Region, 2023
Global Scar Treatment Market- Regional Analysis
Among region, North America is expected to dominate the market over the forecast period. This is attributed to increasing adoption of organic growth strategies such as product launches by key players in the region to expand their product portfolio. For instance, in March 2022, Cocoon Medical, a leading global developer and provider of energy-based aesthetic systems for practitioners, announced the launch of its Primelase diode laser platform. Primelase guarantees a 4.800W maximum power, providing peak performance and highest profitability for the market.
The European region is expected to be the second-largest region in to dominate the market over the forecast period, owing to increasing growth strategies such as product launches by key players in the region expected to drive the market growth over the forecast period. For instance, in September 2021, SkinCeuticals, a provider of skincare products, announced the launch of their latest innovation, Advanced Scar Control. The new semi-occlusive treatment is designed to protect vulnerable skin to help improve the appearance of new and recent scars.
Global Scar Treatment Market– Impact of Coronavirus (COVID-19) Pandemic
Coronavirus disease 2019 (COVID-19) is a highly contagious infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the World Health Organization (WHO) 44,614,437 people were affected globally till October 10, 2022. The coronavirus (COVID-19) pandemic and subsequent lockdown in various countries around the world have impacted the financial health of major companies.
However, the COVID-19 pandemic had a negative impact on the global scar treatment market owing to the decrease in surgical operations performed during the COVID-19 period. For instance, in June 2022, a report published on National Center for Biotechnology Information (NCBI), stated that a decrease of 22.7% and 11.7% was observed in the total number of primary and secondary surgeries.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2022 | Market Size in 2023: | US$ 12,020.5 Mn |
| Historical Data for: | 2017 to 2021 | Forecast Period: | 2023 to 2030 |
| Forecast Period 2023 to 2030 CAGR: | 4.5% | 2030 Value Projection: | US$ 16,335.9 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Bausch Health Companies Inc., Candela Medical, Perrigo Company plc, Sonoma Pharmaceuticals Inc., Hologic Inc., Johnson & Johnson Services Inc., Quantum Health, CCA Industries Inc., AVITA Medical, Revitol Corp, Scarguard labs, Smith+Nephew, Lumenis Be Ltd, Merz Therapeutics, Cynosure, HRA Pharma, GC Aesthetics, Sientra Inc., SkinCeuticals, Cimeosil.com, Honeydew Products, 3V Sigma USA Inc., Syneron Medical Ltd. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Global Scar Treatment Market Segmentation:
The global scar treatment market report is segmented into product type, scar type, end user, and region
Based on Product Type, the market is segmented into topical scar product (gels, creams, oils, and sheets), laser (co2 laser, excimer laser, and pulsed dye laser), surface treatment, and injectable. Out of which, topical scar product segment is expected to dominate the global scar treatment market during the forecast period and this is attributed to increase in the product launches by key players in the market.
Based on Scar Type, the global scar treatment market is segmented into atrophic scars (acne, trauma and surgery), hypertrophic scars and keloids, contractures, stretch marks. Atrophic scars segment is expected to dominate the market over the forecast period and this is attributed to the increase incidence of surgical operations.
Based on End User, the global scar treatment market is segmented into hospitals, clinics, pharmacies and drug stores, e-commerce. Of which, e-commerce segment is expected to dominate the market over the forecast period and this is attributed to the increasing number of scar treatment products available on different E-commerce websites.
Based on Region, the global scar treatment market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. Of which, North America segment is expected to dominate the market over the forecast period and this is attributed to the increasing inorganic growth strategies such as collaboration by key players in the region.
Among all segmentation, product type segment has the highest potential due to increasing incidence of scars due to burn injuries. For instance, in November 2022, an article published on UpToDate, Inc., which is a point-of-care medical resource, stated that at an estimate, there are between 7 and 12 million people (up to 33,000 each day) who sustain burn injuries every year.
Global Scar Treatment Market Cross Sectional Analysis:
Under the product type segment, topical scar product segment held a dominant position in North America region due to increasing incidence of accidents which require surgical operations and thus result in the development of scars. For instance, on 9 January 2023, according to a report published by Centers for Disease Control and Prevention (CDC), each year, around 1.35 million people are killed on roadways around the world.
In end user segment, E-commerce segment is dominant in Asia Pacific region due to increased availability of different scar products available on E-commerce websites. For instance, Alibaba.com, which is a leading E-commerce website in Asia, has around 3000 different products for scar treatment.
Global Scar Treatment Market: Key Developments
On June 12 2022, Syneron Medical Ltd, a cosmetic surgery device manufacturer, acquired Candela Corporation, a laser manufacturing company, under the terms of the merger agreement, Candela shareholders will receive 0.2911 ordinary shares of Syneron for each share of Candela common stock they own. Syneron has issued approximately 6.7 million shares to acquire Candela.
On 28 April 2022, Lumenis Be, Ltd., a global leader in the field of minimally-invasive clinical solutions for the ophthalmology and aesthetic market, announced the launch of triLift, a facial stimulation device targeting three aging elements—structure, contour, and texture—by treating the three tissue layers. The device affects the muscles, the dermal layer, and the epidermal layer.
On 17 August 2021, Merz Therapeutics, a manufacturer of pharmaceutical products, came into a partnership with VENSICA, a medical device company for the needleless delivery of botox to treat scars.
On 28 September 2022, Johnson & Johnson Services, a leading healthcare company, announced an independent new consumer health company, Kenvue, which will be a standalone leading global consumer health company in 2023, subject to legal requirements including consultation with works councils and employee representatives, as required.
Global Scar Treatment Market: Restraint
High cost of laser treatment
The major factors that can hamper growth of the global scar treatment market over the forecast period include high cost of laser treatment for scar removal. For instance, on 27 January 2023, according to PRISTYN CARE, which is a health-tech company that deals into minimal invasive medical and surgical interventions stated that the cost of acne or chicken pox related scar removal is 72.50 to 241.66 U.S. $
Disadvantages associated with scar treatment
The factors that can affect the growth of the global scar treatment market over the forecast period includes disadvantages associated with scar treatment. For instance, in December 2021, according to an article published by WebMD LLC, a source for timely health and medical news and information stated that scar treatment has disadvantages like it may result into milia and hyperpigmentation
Global Scar Treatment Market: Key Players
Major players operating in the global scar treatment market include Bausch Health Companies Inc., Candela Medical, Perrigo Company plc, Sonoma Pharmaceuticals Inc., Hologic Inc., Johnson & Johnson Services Inc., Quantum Health, CCA Industries Inc., AVITA Medical, Revitol Corp, Scarguard labs, Smith+Nephew, Lumenis Be Ltd, Merz Therapeutics, Cynosure, HRA Pharma, GC Aesthetics, Sientra Inc., SkinCeuticals, Cimeosil.com, Honeydew Products, 3V Sigma USA Inc., Syneron Medical Ltd.
Definition: Scar is a fibrous tissue that forms when normal tissue is destroyed by disease, injury, or surgery. For example, scar tissue forms when a wound heals after a cut, sore, burn, or other skin condition, or when an incision (cut) is made into the skin during surgery.
Scars are of various different types it can be a fine line or an abnormal overgrowth of tissue or a pitted hole on the skin. Nearly everyone develops some type of scar, whether from an accident, a surgical procedure, acne or an illness such as chickenpox (varicella). Scars affect people of all ages and genders. A number of treatments are available that may improve a scar's appearance and help make it less visible.
Scar treatment is a process that makes the scars less visible. Treatment options for scars include applying prescription creams, ointments, or gels, surgical removal or treatment, injections, and others.
Market Dynamics
The key market players are focused on brand expansion in various regions in order to increase their presence in the market which is expected to drive the market growth over the forecast period. For instance, in April 2022, HRA Pharma, which is a fast-growing consumer healthcare company, announced that they are going to bring Mederma which is a scar-care brand in U.K., which will enable the citizens in the U.K. to buy three products of Mederma.
The increasing adoption of organic growth strategies such as product launches by key players in the market to expand product portfolio is expected to drive the market growth over the forecast period. For instance, on January 24, 2023, Skinuva MD Medical Designs, Inc., a growing entrepreneurial company, announced the launch of its newest physician developed and solutions driven product, Skinuva Scar+ SPF 30.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients